Comprehensive tobacco cessation program for cancer patients, survivors, and caregivers
Official title: Building a Comprehensive Tobacco Cessation Program for Cancer Patients and Survivors: "A Breath of Fresh Air"
Run by Virginia Commonwealth University · NCT05805722 · Data updated 2026-11-12
This program will try offering gold-standard medications (nicotine replacement, bupropion, or varenicline) plus behavioral counseling to help cancer patients, survivors, and caregivers quit tobacco.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 75 (estimated) |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 1 site (Richmond, Virginia) |
| Status | Recruiting |
| Started | April 12, 2023 |
| Main results expected | September 30, 2029 |
| Study ends | September 30, 2029 |
| Registry record updated | June 30, 2026 |
| Trial ID | NCT05805722 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking VCUHealth patients with a documented cancer diagnosis (active or in remission) who currently use tobacco or have recently quit and can provide informed consent and attend program visits.
✕Probably not a fit
Patients who are not VCUHealth patients, who do not speak English, or who are unwilling or unable to use medications or participate in counseling are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The program integrates evidence-based pharmacotherapy (nicotine replacement therapy, bupropion, or varenicline) with behavioral counseling into routine oncology care to test how well it can be delivered. Investigators will offer the gold-standard treatment to VCUHealth patients with a current or recent history of tobacco use and measure feasibility and acceptability of the procedures. The study focuses on practical implementation within a cancer center population that may face social determinants of health barriers to cessation. Results are intended to guide future efforts to make tobacco treatment a standard, accessible part of cancer care.
Why it matters
Potential benefit: If successful, this program could increase quit rates and improve cancer outcomes and quality of life by making evidence-based tobacco treatment readily available in oncology care.
How similar studies have gone: Prior trials have shown that combining pharmacotherapy with counseling improves cessation rates, though fewer studies have tested comprehensive implementation specifically within cancer care settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form * Stated willingness to comply with study procedures and availability for the duration of the study * Have a documented history of cancer of any type, whether active or in remission * Identify as a current or recently-quit tobacco user Exclusion Criteria: * Not a VCUHealth patient * Non English-speaking
Where it's running
-
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Principal investigator: Livingstone Aduse-Poku, PhD — Virginia Commonwealth University
- Study coordinator: Antonice Wall
- Email: walla2@vcu.edu
- Phone: 804-827-2357
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Automating Tobacco Cessation in Primary Care
This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.
-
Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco
Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.
-
Extended tobacco support for people experiencing homelessness
This program tests whether extending tobacco treatment to 6 months with pharmacist counseling, monthly nicotine replacement deliveries, and phone wellness coaching helps adults experiencing homelessness quit smoking compared with a 3-month package.
-
Trauma-informed smoking cessation support during pregnancy
This project will test a trauma-informed smoking cessation program that combines the 4Rs with the 5As to help pregnant women who smoke and have histories of trauma.
-
Treatment for quitting cigarettes and reducing cannabis use
This study tests if a medication called varenicline can help adults who smoke cigarettes and use cannabis quit smoking and cut down on cannabis use, with support from counseling and online resources.
-
Improving tobacco cessation support for patients in poverty in Utah
This study is testing new ways to help people living in poverty in Utah quit smoking by using support tools and strategies in their healthcare clinics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.